title: Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
authors.affiliation: Department of Clinical Immunology, Poznan University of Medical Sciences, Poznan, Poland.
authors.forename: Miroslaw J
authors.initials: MJ
authors.lastname: Szczepanski
authors.forename: Theresa L
authors.initials: TL
authors.lastname: Whiteside
mesh_terms: D000951:Antigens, Neoplasm / Q000235:genetics*; D014408:Biomarkers, Tumor / Q000235:genetics; D002294:Carcinoma, Squamous Cell / Q000175:diagnosis / Q000235:genetics* / Q000517:prevention & control / Q000628:therapy*; D018890:Chemoprevention; D017024:Chemotherapy, Adjuvant; D015972:Gene Expression Regulation, Neoplastic; D005819:Genetic Markers / Q000235:genetics; D006258:Head and Neck Neoplasms / Q000175:diagnosis / Q000235:genetics* / Q000517:prevention & control / Q000628:therapy*; D006801:Humans; D011379:Prognosis; D012176:Retinoids / Q000378:metabolism
chemical_list: D000951:Antigens, Neoplasm; D014408:Biomarkers, Tumor; D005819:Genetic Markers; C404944:PRAME protein, human; D012176:Retinoids
references.citation: J Cell Physiol. 2011 Feb;226(2):322-30
references.pmid: 20836077
references.citation: J Immunother. 2009 Feb-Mar;32(2):161-8
references.pmid: 19238015
references.citation: B-ENT. 2011;7(1):37-42
references.pmid: 21563555
references.citation: J Cell Biochem Suppl. 1993;17F:18-26
references.pmid: 8412190
references.citation: Cell. 2005 Sep 23;122(6):835-47
references.pmid: 16179254
references.citation: Cancer. 2012 Aug 15;118(16):3882-92
references.pmid: 22281752
references.citation: Cancer Lett. 1988 May;40(1):93-101
references.pmid: 3370632
references.citation: Rev Recent Clin Trials. 2012 Aug;7(3):249-54
references.pmid: 22540907
references.citation: PLoS Med. 2006 Nov;3(11):e442
references.pmid: 17132052
references.citation: Cancer Res. 2006 Nov 15;66(22):10639-42
references.pmid: 17108098
references.citation: Clin Cancer Res. 2011 Sep 1;17(17):5615-25
references.pmid: 21771875
references.citation: Oral Oncol. 2013 Feb;49(2):144-51
references.pmid: 22944049
references.citation: J Natl Cancer Inst. 1994 Jan 19;86(2):140-1
references.pmid: 8271298
references.citation: Leuk Res Treatment. 2012;2012:939021
references.pmid: 23213553
references.citation: Leuk Res. 2011 Sep;35(9):1219-25
references.pmid: 21550659
references.citation: Oncologist. 2004;9(3):302-11
references.pmid: 15169985
references.citation: N Engl J Med. 2001 Dec 27;345(26):1890-900
references.pmid: 11756581
references.citation: Clin Cancer Res. 2011 Oct 1;17(19):6174-84
references.pmid: 21856769
references.citation: Immunity. 1997 Feb;6(2):199-208
references.pmid: 9047241
references.citation: Immunopharmacol Immunotoxicol. 2011 Jun;33(2):241-9
references.pmid: 20929432
references.citation: J Control Release. 2011 Feb 10;149(3):281-91
references.pmid: 20971141
references.citation: Otolaryngol Clin North Am. 2011 Feb;44(1):221-9, vii
references.pmid: 21093631
references.citation: N Engl J Med. 1995 May 25;332(21):1405-10
references.pmid: 7723796